G&A Moulding Technology and RJG have announced at Interplas that they plan to join forces in an acquisition effective from January 1, 2015.
G&A is likely to become “a division” of RJG, however, the company will retain all of its staff and will operate with a “business as usual” policy.
RJG stands to gain greater access to the European market in which G&A has historically enjoyed a strong presence, particularly in the medical sector.
The ethos behind both companies is similar in terms of origins, ethics, approach to technology and approach to business.
"With the acquisition by RJG, we have kept our family ideology and ethics. There were clear synergies between the two companies,” said John Goff, CEO of G&A.
RJG says the acquisition will strengthen its existing global footprint, and result in an organisation with unmatched capabilities to assist customers with consulting, training, and process optimisation services worldwide
Since 1998, G&A has been a highly reputable and successful company serving many industries within the field of injection moulding in the UK, Europe, and worldwide.
“John and his team have a proven reputation as a premier consulting and training organisation that delivers superior value to their clients,” stated Rod Groleau, Chairman and Founder of RJG.
“Advanced training of injection moulders is a key component of our mission and something we do with great pride and commitment. We are excited to be adding G&A’s capabilities to our team and to be adding a training facility in the UK for delivering RJG’s world renown Master Molder training classes,” added Dale Westerman, President & CEO of RJG, Inc.